St. Louis, MO (PRWEB) September 09, 2011
Reliable Biopharmaceutical Corporation has expanded manufacturing capacity for its Lactobionic Acid (LBA) production. The expansion represents a 50% increase in Lactobionic Acid production.
Lactobionic Acid is used in the Pharmaceutical industry as a salt form and to provide osmotic support during organ preservation to prevent cell swelling. Lactobionic Acid is used in the cosmetic and personal care industries as an antioxidant and for mineral supplementation.
“This phase of facility expansion is the first of several anticipated at Reliable Biopharmaceutical Corporation,” said David Feldker, President and CEO. He continued, “We see our High Purity Ingredients product line as a key contributor to our success as we move forward.”
About Reliable Biopharmaceutical Corporation
Founded in 1968, RBC is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RBC has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has 19 DMFs that have been accepted by Regulatory Agencies and has 19 more in various stages of development. RBC's products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RBC also manufactures critical processing aids for the pharmaceutical industry and currently supplies these products to many of the world's leading pharmaceutical and biotechnology companies. RBC is a portfolio company of Med Opportunity Partners, LLC.
About Med Opportunity Partners, LLC
Med Opportunity Partners, LLC (http://www.MedOpportunity.com) is a Greenwich, CT- based operating oriented private equity firm that acquires leading healthcare companies at their growth stage. MEDOP is dedicated to investing in companies that drive healthcare innovation, growth and consolidation. Founded by seasoned healthcare investors and operators, MEDOP partners with companies that can benefit from its extensive industry knowledge, relationships and proven operating and transaction experience. MEDOP receives funding from prominent investors including pension funds, endowments, insurance companies, and private families.
# # #